首页> 外文期刊>Diagnostics >Diagnosis of Upper and Lower Respiratory Tract Bacterial Infections with the Use of Multiplex PCR Assays
【24h】

Diagnosis of Upper and Lower Respiratory Tract Bacterial Infections with the Use of Multiplex PCR Assays

机译:使用多重PCR检测诊断上呼吸道细菌感染和下呼吸道细菌感染

获取原文
           

摘要

The investigation of respiratory infections by molecular techniques provides important information about the epidemiology of respiratory disease, especially during the post-vaccination era. The objective of the present study was the detection of bacterial pathogens directly in clinical samples from patients with upper and lower respiratory tract infections using multiplex polymerase chain reaction (PCR) assays developed in our laboratory. Clinical samples taken over a three-year period (2007–2009) and obtained from 349 patients (adults (n = 66); children (n = 283)) with signs and symptoms of certain upper or lower respiratory tract infections, consisted of: bronchoalveolar lavages (BAL, n = 83), pleural fluids (n = 29), and middle-ear aspirates (n = 237). Overall, 212 samples (61%) were confirmed by culture and/or PCR. Among the positive samples, Streptococcus pneumoniae (mainly serotype 3) was predominant (104/212; 49.0%), followed by non-typable Haemophilus influenzae (NTHi) 59/212; 27.8%) and Streptococcus pyogenes (47/212; 22%). Haemophilus influenzae type b was detected in only three samples. The underlying microbiology of respiratory infections is gradually changing in response to various selective pressures, such as vaccine use and antibiotic consumption. The application of multiplex PCR (mPCR) assays is particularly useful since it successfully identified the microorganisms implicated in acute otitis media or lower respiratory tract infections in nearly 75% of patients with a positive result compared to conventional cultures. Non-culture identification of the implicated pneumococcal serotypes is also an important issue for monitoring pneumococcal infections in the era of conjugate pneumococcal vaccines.
机译:通过分子技术对呼吸道感染的调查提供了有关呼吸道疾病流行病学的重要信息,尤其是在疫苗接种后的时期。本研究的目的是使用我们实验室开发的多重聚合酶链反应(PCR)方法,直接从上呼吸道和下呼吸道感染患者的临床样本中检测细菌病原体。为期三年(2007-2009),并从349例具有某些上呼吸道或下呼吸道感染的症状和体征的患者(成人(n = 66);儿童(n = 283))中收集了以下临床样品:支气管肺泡灌洗(BAL,n = 83),胸腔积液(n = 29)和中耳抽吸物(n = 237)。总体而言,通过培养和/或PCR确认了212个样品(61%)。在阳性样本中,肺炎链球菌(主要是血清型3)占主要比例(104/212; 49.0%),其次是非典型流感嗜血杆菌(NTHi)59/212;而肺炎链球菌(NTHi)占59.212。 27.8%)和化脓性链球菌(47/212; 22%)。仅在三个样本中检测到b型流感嗜血杆菌。呼吸道感染的潜在微生物正在响应各种选择压力(例如使用疫苗和服用抗生素)而逐渐变化。多重PCR(mPCR)分析的应用特别有用,因为它成功地在近75%的患者中鉴定出与急性中耳炎或下呼吸道感染有关的微生物,与常规培养相比,结果是阳性的。涉及肺炎球菌血清型的非文化鉴定也是在结合肺炎球菌疫苗时代监测肺炎球菌感染的重要问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号